Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / HROWM - Harrow, Inc. (HROW) Q1 2025 Earnings Call Transcript


HROWM - Harrow, Inc. (HROW) Q1 2025 Earnings Call Transcript

2025-05-10 18:17:15 ET

Harrow, Inc. (HROW)

Q1 2025 Results Conference Call

May 9, 2025 8:00 AM ET

Company Participants

Jamie Webb - Director, Communications & IR

Mark Baum - CEO

Andrew Boll - CFO

Conference Call Participants

Thomas Flaten - Lake Street Capital Markets

Chase Knickerbocker - Craig Hallum

Jeffrey Cohen - Ladenburg Thalmann and Company

Yi Chen - H. C. Wainwright

Mayank Mamtani - B. Riley Securities

Presentation

Operator

Good morning, and welcome to Harrow's First Quarter 2025 Earnings Conference Call. My name is Shannon, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later we will conduct the question-and-answer session. As a reminder, this conference is being recorded.

I would now like to turn the call over to Jamie Webb, Director of Communications and Investor Relations for Harrow.

Jamie Webb

Thank you, operator. Good morning, and welcome to Harrow's first quarter 2025 earnings conference call. Before we begin today, let me remind you that the company's remarks may include forward-looking statements within the meaning of federal securities laws. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond Harrow's control, including risks and uncertainties described from time to time in its SEC filings, such as the risks and uncertainties related to the company's ability to make commercially available its FDA-approved products and compounded formulations and technologies and FDA approval of certain drug candidates in a timely manner or at all.

For a list and description of those risks and uncertainties, please see the Risk Factors section of the company's most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. Harrow's results may differ materially from those projected.

Harrow disclaims any intention or obligation to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise. This conference call contains time-sensitive information and is accurate only as of today.

Additionally, Harrow will refer to non-GAAP financial metrics, specifically adjusted EBITDA and/or adjusted earnings as well as core results such as core gross margin, core net income and core diluted net income per share. A reconciliation of any non-GAAP measures to the most directly comparable GAAP measures is included in the company's earnings release and letter to stockholders, both of which are available on the website....

For further details see:

Harrow, Inc. (HROW) Q1 2025 Earnings Call Transcript

Stock Information

Company Name: Harrow Inc. 11.875% Senior Notes due 2027
Stock Symbol: HROWM
Market: NASDAQ
Website: harrowinc.com

Menu

HROWM HROWM Quote HROWM Short HROWM News HROWM Articles HROWM Message Board
Get HROWM Alerts

News, Short Squeeze, Breakout and More Instantly...